
TheHawk👀
110 posts




$CING patiently waiting 10!






While the broader market was bleeding, a small, overlooked biotech quietly held its ground. I’m talking about $CING, again. I believe in the management, the product, and the market they’ve positioned themselves in, and it looks like Wall Street is starting to notice. Price has been holding and grinding higher, and above $7 the volume profile is basically no man’s land. The setup is clean: No warrants. No options chain. No convertibles. Recent offering already done. Nobody standing in the way. $CING’s time-released ADHD platform delivers a steady dose of an already approved drug, reducing crashes and spikes. Phase 3 is complete, with an FDA decision expected by May at the latest. If you know anyone with ADHD or ADD, you know how big this is. My price target remains $20 by summer.


BREAKING: Al Jazeera (Qatar) reports that Iran, China and Russia will launch a joint naval exercise in the Gulf of Oman and the Indian Ocean in the coming days



ON MY RADAR: $ASTI Ascent Solar Technologies is a classic binary play. It’s a distressed micro-cap (~$30M market cap) that many call "uninvestable trash" due to historical dilution. However, it holds a proprietary thin-films solar technology that could find it's niche in the space solar market currently dominated by titans like $RKLB and $RDW. If they execute, there could be a massive repricing. If not, it could go to zero.



Two people to ignore as if your life depended on it. $aqst











